CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 59 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,579 | -46.4% | 186,410 | -6.1% | 0.02% | -50.0% |
| Q2 2023 | $238,166 | +2.5% | 198,472 | -0.1% | 0.05% | -13.2% |
| Q1 2023 | $232,399 | +50.1% | 198,632 | +1.4% | 0.05% | +35.9% |
| Q4 2022 | $154,797 | -35.5% | 195,946 | -1.2% | 0.04% | -40.9% |
| Q3 2022 | $240,000 | +32.6% | 198,405 | +0.8% | 0.07% | +29.4% |
| Q2 2022 | $181,000 | -47.8% | 196,867 | +1.6% | 0.05% | -47.4% |
| Q1 2022 | $347,000 | +19.2% | 193,715 | +2.6% | 0.10% | +18.3% |
| Q4 2021 | $291,000 | +3.6% | 188,796 | +36.6% | 0.08% | -7.9% |
| Q3 2021 | $281,000 | -40.5% | 138,213 | +2.0% | 0.09% | -42.2% |
| Q2 2021 | $472,000 | +139.6% | 135,508 | +22.3% | 0.15% | +116.9% |
| Q1 2021 | $197,000 | – | 110,787 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |